AVIGI Therapeutics

Biotechnology Research • • 1-10 Employees

Company overview

Headquarters	XX
Website	avigitx.com
NAICS	541714
Founded	2024
Employees	1-10

Key Contact at AVIGI Therapeutics

Vincent Lit

Founder & CEO

AVIGI Therapeutics Email Formats

AVIGI Therapeutics uses 1 email format. The most common is {first name} (e.g., john@avigitx.com), used 100% of the time.

Format	Example	Percentage
{first name}	john@avigitx.com	100%

About AVIGI Therapeutics

We're pioneering a new era in drug design and development with rationally designed medicines leveraging human capabilities in advanced chemistry and biotech advancements. Our approach centers around biomimicy selectively targeting central cascades that drive disease. Our lead program is in development in kidney disease and has the potential to modify disease outcomes for millions of patients.

AVIGI Therapeutics revenue & valuation

Annual revenue	$342,220
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,100,000
Total funding	$383,600

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

AVIGI Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore AVIGI Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2025-05-04	2	$383,600

Funding Insights

$383,600

Total funding amount

$383,600

Most recent funding amount

Number of funding rounds

Frequently asked questions

AVIGI Therapeutics is located in XX.

AVIGI Therapeutics was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.

AVIGI Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

AVIGI Therapeutics has raised a total of $383,600 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at AVIGI Therapeutics

Vincent Lit

Founder & CEO

4.8

40,000 users